Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA hotline has received over 75% of dietary supplement complaints in 1996.

This article was originally published in The Tan Sheet

Executive Summary

FDA HOTLINE HAS RECEIVED OVER 75% OF DIETARY SUPPLEMENT COMPLAINTS made to the agency for such products in the first six months of 1996, based on information from the agency's Office of Special Nutritionals current as of July 5. The agency recorded approximately 295 adverse reactions to dietary supplements in the first half of the year. Of those, 195, or approximately 78%, are listed as received through the agency's adverse reaction hotline. A substantial number of the complaints relate to ephedra products.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel